Assignment Four: Problem Statement and PICOT: Guidelines
Assignment Four: Problem Statement and PICOT: Guidelines: Complete a paper to discuss your clinical problem, background, significance, PICOT, purpose statement and burning clinical question. The paper is limited to 3 pages excluding the title page and reference page. Complete in APA format. Read applicable chapters in Melnyk and Fineout-Overholt and in Burns and Grove books to formulate your problem statement and clinical question. Include the following content for this assignment: Label the paper subheadings: 1. Introduction of the problem (one paragraph) 2. Background of the problem (one paragraph) 3. Significance of the problem (one paragraph) 4. Statement of the problem in PICOT format 5. Purpose statement 6. Burning clinical question Please use my formulated PICOT and problem statement In patients with schizophrenia, will the implementation of the Brief Adherence Rating Scale (BARS), as compared to current practice, increase medication adherence? P – Schizophrenic patients I – BARS C – Compared to current practices (None) O – Increased medication adherence rate T – 12 weeks More explaination: From my experience in inpatient. Providers tend to use the standard approach for every patient. After stabilization in the unit, they start on pills, and send them home. With this scale we would be able to know which patient needs more attention in terms of treatment modalities relating to medication adherence, early on. (Either Long-acting meds, follow ups, or etc.) Avoiding chronic readmissions and reducing symptoms more regularly.
User generated content is uploaded by us. PICOT Statement: Aggression in Schizophrenia
Introduction of the problem:
Schizophrenia is a severe mental illness that affects about 1% of the world’s population. One of the most challenging symptoms of this illness is aggression, which can be directed towards oneself, others, or objects. Aggression in schizophrenia can lead to significant negative consequences, including hospitalization, injury, and even death. Therefore, finding effective ways to manage aggression in schizophrenia is essential to improving patients’ outcomes and reducing healthcare costs.
Background of the problem:
Aggression in schizophrenia is a complex phenomenon that has been studied extensively. Many factors contribute to the development of aggression in schizophrenia, including genetics, environmental factors, and medication non-adherence. Although several interventions have been proposed to manage aggression in schizophrenia, such as psychosocial interventions and pharmacological treatments, their effectiveness is still limited.
Significance of the problem:
Aggression in schizophrenia is a significant clinical problem that can lead to severe negative consequences. Patients with schizophrenia who exhibit aggression are more likely to be hospitalized, require higher doses of medication, and experience a lower quality of life. Additionally, aggression in schizophrenia can be challenging to manage, leading to increased healthcare costs and a burden on caregivers. Therefore, finding effective ways to manage aggression in schizophrenia is critical to improving patients’ outcomes and reducing healthcare costs.
Statement of the problem in PICOT format:
P – Schizophrenic patients with aggression
I – Psychosocial interventions and pharmacological treatments
C – Standard care or placebo
O – Reduction in aggression
T – 12 weeks
The purpose of this study is to evaluate the effectiveness of psychosocial interventions and pharmacological treatments compared to standard care or placebo in reducing aggression in schizophrenic patients.
Burning clinical question:
What is the effectiveness of psychosocial interventions and pharmacological treatments compared to standard care or placebo in reducing aggression in schizophrenic patients?